Neuralstem loss lower in quarter

Neuralstem Inc., a Germantown-based biotechnology company, narrowed its loss in the third quarter. Neuralstem reported a net loss of $4.5 million, or 5 cents per share, compared with $6.7 million, or 9 cents, for the same period in 2013. The company said this year’s loss was lower because last year’s quarter included non-cash expenses of $1.9 million related to modifications of stock purchase warrants.